P&G celebrates return of ‘Have You Tried This Yet?’ with NYC media event
NEW YORK — To celebrate and promote the return of its “Have You Tried This Yet?” campaign, Procter & Gamble held an exclusive media event in New York on Tuesday evening spotlighting some of its most innovative products and offering complimentary beauty services and product demos.
The event, held at The Theater at Cedar Lake in New York City, also featured appearances by Kari Byron, host of the television shows “Mythbusters” and “Head Rush,” and celebrity stylist Irma Martinez. Both Byron and Martinez are working with P&G as campaign spokeswomen and will be featured in “Have You Tried This Yet?” brand demonstration videos for such brands as Bounty ExtraSoft and Clairol Nice ‘n Easy Color Blend Foam.
During Tuesday evening’s event — attended by consumer and trade press and bloggers — attendees could, for example, learn about Clairol Nice ‘n Easy Color Blend Foam and secure a color consultation to see how a foam hair color works with hair; receive a makeover experience from CoverGirl with the Natureluxe Silk foundation and Gloss Balm makeup; and get a consultation on Crest 3D White 2-Hour Express Whitestrips. The event also featured demos of such household brands as Bounty ExtraSoft and Always Infinity.
As previously reported by Drug Store News, P&G will reach consumers nationwide through a variety of touch-points, including print advertising, direct response TV and iMedia. Also, P&G BrandSaver, a complimentary coupon booklet, will feature more than $102 in savings, including values on the campaign’s feature products. The BrandSaver can be found in local newspapers throughout the country on Oct. 30.
Distribution solutions, technology solutions businesses aid McKesson’s Q2
SAN FRANCISCO — McKesson said its distribution solutions and technology solutions businesses helped drive the company’s operating results for the second quarter ended Sept. 30.
For its distribution solutions business, McKesson reported that revenue was up 10% to $29.4 billion. The increase, the wholesaler said, was primarily driven by growth in U.S. pharmaceutical direct distribution and services revenues (which rose to nearly $26 billion), as well as the acquisition of US Oncology, the company said.
Meanwhile, revenue rose 7% for the wholesaler’s technology solutions, from $770 million in second quarter 2010 to $825 million in this year’s second quarter. McKesson attributed the performance to "solid progress on achieving certain customer implementation milestones."
The achievements prompted the wholesaler to raise its full-year earnings forecast.
“I am pleased with McKesson’s second-quarter operating results, with strong execution from both distribution solutions and technology solutions driving earnings growth,” McKesson chairman and CEO John Hammergren said. “Based on the momentum from our first-half results, we are raising our previous outlook for the fiscal year and now expect adjusted earnings between $6.19 and $6.39 per diluted share for the fiscal year ending March 31, 2012.”
Overall revenue for McKesson rose from to $30.2 billion, reflecting a 10% increase from the year-ago period. Second-quarter earnings per share, however, dropped to $1.18 from $1.25 in the year-ago period. Net income also fell from $296 million to $327 million.
For its operating income, the company saw an increase of $61 million to $478 million, compared with the year-ago period.
Coalition calls on consumers to ask Congress, FTC to oppose ESI-Medco merger
WASHINGTON — The Preserve Community Pharmacy Access NOW! coalition, which is a coalition of consumers, businesses and community-based pharmacists from across the country that have come together to oppose the planned mega-merger of Express Scripts and Medco Health Solutions, has issued a call to action to protect Americans from rising costs and decreased access to health care by stopping the planned merger of the PBMs.
The call to action, posted on the coalition’s website, outlines what it says are the negative impacts of approving the merger and calls on consumers to sign a petition that will be sent to the Federal Trade Commission and members of Congress opposing the merger. In addition, consumers are encouraged to send letters or make phone calls to their local representatives urging them to oppose the merger.
"Approving this merger — combining two of the nation’s largest PBM companies into a big, consolidated PBM with excessive control over the health care of tens of millions of Americans — would put quality care even further from reach of a general population already struggling. Such an outcome cannot be taken lightly," stated former Congresswoman Eva M. Clayton, chairwoman for the PCPAN coalition. "Americans cannot afford, now or ever, to have their healthcare costs and access to pharmacy services dictated by a mega-PBM that puts profits before people."
"Not all mergers are bad, but there is a reason that this particular one is the target of much scrutiny," added Dennis Archer, chief legal counsel for PCPAN, which is a project of Pharmacy Choice and Access Now. "The merger between Express Scripts and Medco would create a mega pharmacy benefit management company with excessive control and concentrated market share that could have serious implications for consumers and for U.S. health care in general. It should not be allowed to move forward."